Comparison of Deferoxamine, Deferiprone and Deferasirox Iron-Chelating Agents in Reducing Serum Ferritin Levels in Patients with Thalassemia Major

1] Beta-thalassemia ... [2] The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel ... [3] Defining autoimmune hemolytic anemia: a systematic review of the terminology ... [4] Durch β-Thalassaemia minor maskierte autoimmune perniziöse ... [5] How I treat transfusional iron ... [6] Harrison's principles of internal ... [7] Pathophysiology of ... [8] A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients ... [9] Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects ... [10] Safety, tolerability, and pharmacokinetics of ICL670, a new orally active ironchelating agent in patients with transfusion-dependent iron overload ... [11] Current approach to iron chelation ... [12] Cross-talk between available guidelines for the management of patients with ... [13] Light and shadows in the iron chelation treatment ... [14] Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with ... [15] Accuracy of magnetic resonance imaging in diagnosis of liver iron overload ... [16] Iron chelation in thalassemia ... [17] Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia ... [18] Efficacy of deferasirox in reducing and preventing cardiac iron overload in ... [19] Iron overload in thalassemia and related conditions: therapeutic goals and assessment of ... [20] Long-term efficacy of oral deferiprone in management of iron overload in ... [21] Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients ... [22] Deferiprone versus deferoxamine in patients with thalassemia major ... [23] Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone ... [24] Comparing the efficacy of Dexeroyx (Osveral) and Deferoxamine ... [25] Survival and complications in patients with thalassemia major treated ...